金志恒,张慜鋆,董继军,王红,邹容
JIN Zhiheng,ZHANG Minyun,DONG Jijun,WANG Hong,ZOU Rong

• 1:荆州市妇幼保健院
• 2:荆州市第二人民医院

摘要(Abstract)：

目的:探讨米索前列醇联合缩宫素对产妇产后出血的治疗效果。方法:将80例产妇分为观察组与对照组,对照组产妇产后给予缩宫素子宫体注射,观察组在对照组治疗的基础上,肛塞给予400μg米索前列醇,观察两组产妇产后出血发生率、产后2、24 h内的出血量、用药后血红蛋白(Hb)和红细胞比容(Hct),并观察两组患者不良反应发生情况。结果:与对照组比较,观察组产妇产后2 h出血量及产后24 h出血发生率显著降低,差异有统计学意义(P<0.05);两组产妇在用药前、后Hct及Hb均降低;对照组产妇的细胞比容及Hb较观察组降低更明显,差异有统计学意义(P<0.05);与对照组比较,观察组产妇的不良反应发生率显著降低,差异有统计学意义(P<0.05)。结论:在缩宫素的基础上联谊米索前列醇能显著降低产妇产后出血情况及产后出血量,安全性高。
Objective: To explore the effect of misoprostol combined with oxytocin in the prevention and control of postpartum hemorrhage. Methods: 80 cases of lying-in women were selected in our hospital from February 2015 to March 2016 for the study and randomly divided into the observation group and the control group. The control group were given oxytocin in the prevention and control of postpartum hemorrhage,while the observation group received misoprostol as well as oxytocin in the prevention and control of postpartum hemorrhage. The two groups were observed in the incidence rate of postpartum hemorrhage,the volume of postpartum bleeding in in 2 h and 24 h and the contrast of hemoglobin( Hb) and hematocrit( Hct) after treatment. The incidence of adverse reactions of the patients of both groups was also observed. Results: The incidence rate of postpartum hemorrhage in 2 h and the postpartum hemorrhage volume in 24 h in the observation group were significantly lower compared with those in the control group. The difference was statistically significant( P < 0. 05); Hct and Hb of the lyingin women of both groups decreased before and after medications. The maternity Hct and Hb of the control group decreased more significantly than that of the observation group,and the differenc was statistically significant( P < 0. 05); The rate of maternal adverse reaction in the observation group was significantly reduced compared with the control group,and the difference is statistically significant( P <0. 05). Conclusion: Misoprostol combined with oxytocin can significantly reduce the incidence of maternal postpartum hemorrhage and postpartum bleeding volume,with high safety and without serious adverse reactions. It is worth of clinical application.

关键词(KeyWords)： 米索前列醇;缩宫素;产后出血;治疗效果
misoprostol;oxytocin;postpartum hemorrhage;curative effect

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 金志恒,张慜鋆,董继军,王红,邹容
JIN Zhiheng,ZHANG Minyun,DONG Jijun,WANG Hong,ZOU Rong

DOI: 10.19367/j.cnki.1000-2707.2017.10.025

参考文献(References)：

• [1]梁朝霞,陈丹青.产后出血的高危因素和流行病学新特点[J].实用妇产科杂志,2012(11):897-899.
• [2]赵晓颖.缩宫素联合米索前列醇治疗产后出血50例的临床效果分析[J].中国妇幼保健,2014(5):807-808.
• [3]杨梅枝,周莉.子宫收缩乏力性产后出血产妇应用米索前列醇与缩宫素联合治疗的临床效果分析[J].临床合理用药,2014(5):41-42.
• [4]陈玉萍.缩宫素联合米索前列醇防治子宫收缩乏力性产后出血临床观察[J].中国优生优育,2013(3):179-181.
• [5]宋春.缩宫素及米索前列醇在预防产后出血中的应用观察[J].中国现代药物应用,2013(5):67-68.
• [6]瞿丽娟.米索前列醇联合缩宫素预防产后出血的临床效果观察[J].医学理论与实践,2015(19):2672-2673.
• [7]何志英.缩宫素不同用药方式在剖宫产术中的应用效果对比[J].临床合理用药杂志,2015(15):110-111.
• [8]张晶,付荣,庞艳丽.米索前列醇联合缩宫素防治产后出血疗效观察[J].医药论坛杂志,2013(2):51.
• [9]李小艳.米索前列醇配伍缩宫素在治疗产后宫缩乏力性出血中的效果观察.中国妇幼保健,2012(9):1416-1417.
• [10]Alcides P,Filomena N,Sonia P,et al.Compressive uterine sutures to treat postpartum bleeding secondary to uterineatony[J].Obstet Gynecol,2005(03):569.

文章评论(Comment)：